Islamic and Scientific Views on The Law of Using Urine Samples as Candidates for Early Detection of Cancer
DOI:
https://doi.org/10.22515/shahih.v7i2.5548Keywords:
Keywords: Urine Samples, Cancer, Islamic Law, Islamic Perspectives and ScienceAbstract
Abstract
The growing prevalence of cancer patients is a significant obstacle to global human growth. Prostate carcinoma is one of the types of cancer that kills the most men. The second most frequently diagnosed kind of carcinoma is prostate cancer (Pca), which is also the sixth biggest cause of death in males globally. Urine can be a candidate for early diagnosis of non-invasive cancer, however the rule on the use of urine as a sample in Islam has not yet been thoroughly addressed. Prostate cancer testing is still an intrusive procedure. The goal of this study was to ascertain the legality of using urine samples as potential candidates for the early identification of cancer from both an Islamic and scientific standpoint. Meta-analysis is combined with a qualitative methodology. According to the study's findings, urine may be a candidate for the early detection of cancer. Legally speaking, urine can be used as long as it is not applied directly to patients either topically or orally in order to prevent it from becoming haram. This is because the authors were unable to find any evidence to support the prohibition of using urine on patients.
References
Abaadi, Abi Thayyib Muhammad Syamsu al-Haq al-Azim, Aun alMa`bud Syarh Sunan Abu Daud, Beirut: Dar al Kutb alIlmiyah, 1998.
Al-Ashqalani, Ahmad Ibn Ali Ibn Hajar, Fath al-Bari Syarh Shahih alBukhari, 4th edition, Beirut: Dar al Kutb al-Ilmiyah, 2000.
Alawi, Ibn Khalifah, Mausa’a Fatwa an-Nabi, Beirut: Dar al-Ilmiyah, 1992.
Al-Bukhari, Shahih al-Bukhari, Beirut: Dar al Kutb al-Ilmiyah, 1998.
----, Shahih al-Bukhari, Semarang: Toha Putra.
Al-Damasyqi, Al-`Alamah Muhammad Ibn Abdurrahman, Fiqh Empat Mazhab, trans. by Abdullah Zaki Al-Khaf, Bandung: Hasyimi Press, 2004.
Al-Qardhawy, Yusuf, Halal Dan Haram Dalam Islam, trans. by Wanid Ahmadi, Solo: Era Intermedia, 2003.
Al-Qurthubi, al-Jami` al-Ahkam al-Qur`an, Beirut: Dar al- Fikr, 1995.
Al-San'an, Sabulu as-Salam, Bandung: Dahlan. Al-Saukani, Fath al-Qadir, Beirut: Dar al- Fikr, 1992.
Al-Shabuni, Rawai’ut al-Batan, Tafsir Ayat al-Ahkam Min Qur’an, Beirut: Dar al Kutb al-Islamiyah.
Bunting, P. S. (2002). Screening for prostate cancer with prostate-specific antigen: Beware the biases. Clinica Chimica Acta, 315(1–2), 71–97. https://doi.org/10.1016/S0009-8981(01)00717-3
Chaniago, S. (2011). FIKIH DAN KESEHATAN. Jurnal Ilmiah Syari’ah, 10(2), 162–170.
Chen, J., Bai, T., Wu, F. X., Zhu, S. L., Liu, J. J., Li, H., Luo, H. L., Fan, X. H., & Li, L. Q. (2016). miR-22-3p suppresses cell proliferation by regulating SP1 in hepatocellular carcinoma. International Journal of Clinical and Experimental Pathology, 9(5), 5437–5444.
Dai, X., Fang, X., Ma, Y., & Xianyu, J. (2016). Benign prostatic hyperplasia and the risk of prostate cancer and bladder cancer a meta-analysis of observational studies. Medicine (United States), 95(18), e3493. https://doi.org/10.1097/MD.0000000000003493
Eskra, J. N., Rabizadeh, D., Pavlovich, C. P., Catalona, W. J., & Luo, J. (2019). Approaches to urinary detection of prostate cancer. Prostate Cancer and Prostatic Diseases. https://doi.org/10.1038/s41391-019-0127-4
Foster, H. E., Barry, M. J., Dahm, P., Gandhi, M. C., Kaplan, S. A., Kohler, T. S., Lerner, L. B., Lightner, D. J., Parsons, J. K., Roehrborn, C. G., Welliver, C., Wilt, T. J., & McVary, K. T. (2018). Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline. Journal of Urology, 200(3), 612–619. https://doi.org/10.1016/j.juro.2018.05.048
Graham, T. G. W., Darzacq, C. D., Dailey, G. M., Nguyenla, X. H., Dis, E. Van, Esbin, M. N., Abidi, A., Stanley, S. A., Darzacq, X., & Tjian, R. (2021). Open-source RNA extraction and RT-qPCR methods for SARS-CoV-2 detection. PLoS ONE, 16(2 February), 1–24. https://doi.org/10.1371/journal.pone.0246647
Hessels, D., & Schalken, J. A. (2013). Urinary biomarkers for prostate cancer: A review. Asian Journal of Andrology, 15(3), 333–339. https://doi.org/10.1038/aja.2013.6
Hessvik, N. P., & Llorente, A. (2018). Current knowledge on exosome biogenesis and release. Cellular and Molecular Life Sciences, 75(2), 193–208. https://doi.org/10.1007/s00018-017-2595-9
Hirschfeld, M., Rücker, G., Weiß, D., Berner, K., Ritter, A., Jäger, M., & Erbes, T. (2020). Urinary Exosomal MicroRNAs as Potential Non ‑ invasive Biomarkers in Breast Cancer Detection. Molecular Diagnosis & Therapy, 0123456789. https://doi.org/10.1007/s40291-020-00453-y
Li, J., Guan, X., Fan, Z., Ching, L. M., Li, Y., Wang, X., Cao, W. M., & Liu, D. X. (2020). Non-invasive biomarkers for early detection of breast cancer. Cancers, 12(10), 1–28. https://doi.org/10.3390/cancers12102767
MacKintosh, F. R., Sprenkle, P. C., Walter, L. C., Rawson, L., Karnes, R. J., Morrell, C. H., Kattan, M. W., Nawaf, C. B., & Neville, T. B. (2016). Age and prostate-specific antigen level prior to diagnosis predict risk of death from prostate cancer. Frontiers in Oncology, 6(JUN), 1–7. https://doi.org/10.3389/fonc.2016.00157
Martignano, F., Rossi, L., Maugeri, A., Gallà, V., Conteduca, V., De Giorgi, U., Casadio, V., & Schepisi, G. (2017). Urinary RNA-based biomarkers for prostate cancer detection. Clinica Chimica Acta, 473(August), 96–105. https://doi.org/10.1016/j.cca.2017.08.009
Martínez-Fernández, M., Paramio, J. M., & Dueñas, M. (2016). RNA Detection in Urine: From RNA Extraction to Good Normalizer Molecules. Journal of Molecular Diagnostics, 18(1), 15–22. https://doi.org/10.1016/j.jmoldx.2015.07.008
Ng, K., Stenzl, A., Sharma, A., & Vasdev, N. (2021). Urinary biomarkers in bladder cancer: A review of the current landscape and future directions. Urologic Oncology: Seminars and Original Investigations, 39(1), 41–51. https://doi.org/10.1016/j.urolonc.2020.08.016
Pérez-Rambla, C., Puchades-Carrasco, L., García-Flores, M., Rubio-Briones, J., López-Guerrero, J. A., & Pineda-Lucena, A. (2017). Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia. Metabolomics, 13(5), 1–12. https://doi.org/10.1007/s11306-017-1194-y
Sarko, D. K., & McKinney, C. E. (2017). Exosomes: Origins and therapeutic potential for neurodegenerative disease. Frontiers in Neuroscience, 11(FEB), 1–7. https://doi.org/10.3389/fnins.2017.00082
Schalken, J. A. (2014). Clinical use of novel urine and blood based prostate cancer biomarkers: a review. Clinical Biochemistry, 47(10–11), 889–896. https://doi.org/10.1016/j.clinbiochem.2013.10.023
Souhaila Bouatra, Farid Aziat, Rupasri Mandal, An Chi Guo, Michael R. Wilson, Craig Knox, Trent C. Bjorndahl, Ramanarayan Krishnamurthy, Fozia Saleem, Philip Liu, Zerihun T. Dame, Jenna Poelzer, Jessica Huynh, Faizath S. Yallou, Nick Psychogios, Edison Do, D. S. W. (2013). The Human Urine Metabolome. PLoS ONE, 8(9).
Van Niel, G., Porto-Carreiro, I., Simoes, S., & Raposo, G. (2006). Exosomes: A common pathway for a specialized function. Journal of Biochemistry, 140(1), 13–21. https://doi.org/10.1093/jb/mvj128
Wenda-piesik, A., & Buszewski, B. (2022). Analysis of VOCs in Urine Samples Directed towards of Bladder Cancer Detection. 1–14.
Wu, D., Ni, J., Beretov, J., Cozzi, P., Willcox, M., Wasinger, V., Walsh, B., Graham, P., & Li, Y. (2017). Urinary biomarkers in prostate cancer detection and monitoring progression. Critical Reviews in Oncology/Hematology, 118(August), 15–26. https://doi.org/10.1016/j.critrevonc.2017.08.002
Yenti, E. (2020). TERAPI URIN MENURUT (H. A. Alwana (ed.)). WADE group.
Yuri, P., Wangge, G., Abshari, F., Satjakoesoemah, A. I. T. W. H., Perdana, N. R., Wijaya, C. D. K., Tansol, C., Tigor, A., Safriadi, F., Kadar, D. D., Warli, S. M., Rochadi, S., Danarto, Hakim, L., Djatisoesanto, W., Hardjowijoto, S., Mochtar, C. A., Umbas, R., & Hamid, A. R. iza. A. H. (2015). Indonesian prostate cancer risk calculator (IPCRC): an application for predicting prostate cancer risk (a multicenter study). Acta Medica Indonesiana, 47(2), 95–103.
Zhang, C., Leng, W., Sun, C., Lu, T., Chen, Z., Men, X., Wang, Y., Wang, G., Zhen, B., & Qin, J. (2018). Urine Proteome Profiling Predicts Lung Cancer from Control Cases and Other Tumors. EBioMedicine, 30, 120–128. https://doi.org/10.1016/j.ebiom.2018.03.009
Downloads
Published
How to Cite
Issue
Section
Citation Check
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
This ejournal system and its contents are licensed under
a Creative Commons Attribution-NonCommercial 4.0 International License
